That is exactly what has happened. I wonder what the costs of the double blinded trial are anticipated to be? Interest from the big boys comes with the Covid results. Regulatory approval is the main goal here. There is still risk until that happens. At .115 it's a risk I can live with. I hope the current buyers are of the same view.
Ann: Proposed Acquisition of ResApp Health by Pfizer, page-405
-
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)